Patents by Inventor Ian Antheni MYLES

Ian Antheni MYLES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20210169943
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: January 25, 2021
    Publication date: June 10, 2021
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10980846
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: April 20, 2021
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10946048
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: March 16, 2021
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10946049
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: March 16, 2021
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20200254029
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: April 14, 2020
    Publication date: August 13, 2020
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10682379
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: June 16, 2020
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10668114
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: June 2, 2020
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10653727
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: May 19, 2020
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190381112
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: July 25, 2019
    Publication date: December 19, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10500238
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: December 10, 2019
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190343895
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: July 25, 2019
    Publication date: November 14, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190343896
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: July 25, 2019
    Publication date: November 14, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190192580
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 27, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190175667
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 13, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190167735
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 6, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10293005
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: May 21, 2019
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190142873
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: January 10, 2019
    Publication date: May 16, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190142874
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: January 16, 2019
    Publication date: May 16, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS
    Publication number: 20190076486
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Inventors: Ian Antheni MYLES, Sandip K. DATTA
  • Use of gram negative species to treat atopic dermatitis
    Patent number: 10206957
    Abstract: Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: February 19, 2019
    Assignee: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Ian Antheni Myles, Sandip K. Datta